Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

By A. Bergquist, A. Ekbom, R. Olsson, Dan Kornfeldt, L. Lööf, Å. Danielsson, R. Hultcrantz, S. Lindgren, H. Prytz, H. Sandberg-Gertzén and 3 more. Journal of Hepatology, 2002

702 citations recorded by the source corpus.

Subfields: Hepatology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/d992eefa25d592d76acea9dc5a27d0c7960f5eb4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Karlsen
2. U. Beuers
3. T. Folseraas
4. K. Boonstra
5. D. Thorburn
6. M. Vesterhus
7. P. Invernizzi
8. M. Trauner

Citations in the corpus

• Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. (2012, background): “PSC is strongly associated with inflammatory bowel diseases (IBD), most often ulcerative colitis, and patients have an increased risk for developing colorectal and hepatobiliary malignancies [3,4].”
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases. (2009, background): “The risk for pancreatic carcinoma was 14-fold increased in a Swedish cohort of PSC patients in comparison to a matched-control population [103], but its incidence in PSC is markedly lower than that of hepatobiliary malignancies, and regular screening strategies are, therefore, not recommended at pre”
• Primary sclerosing cholangitis - a comprehensive review. (2017, background): “Whether pancreatic cancer truly occurs at increased frequencies as suggested by some authors (53), or represents”